Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)

Q: What does CUSIP 00773U108 represent in this 13F holders report?

CUSIP 00773U108 is the security identifier for ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share in Q1 2021?

131 institutional investors reported ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 00773U108

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 22,163,711
Total 13F shares: 95,104,058
Share change: +923,679
Total reported value: $937,859,079
Put/Call ratio: 364%
Price per share: $9.86
Number of holders: 131
Value change: +$7,873,874
Number of buys: 51
Number of sells: 78

Quarterly Holders Quick Answers

What is CUSIP 00773U108?
CUSIP 00773U108 identifies ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 00773U108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	43%	9,502,383	$103,006,000	—	31 Dec 2020	13F
Avoro Capital Advisors LLC	13F	Company	36%	8,000,000	$86,720,000	—	31 Dec 2020	13F
RTW INVESTMENTS, LP	13F	Company	33%	7,227,364	$78,345,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	32%	7,042,768	$76,343,000	—	31 Dec 2020	13F
ORBIMED ADVISORS LLC	13F	Company	25%	5,501,144	$59,632,000	—	31 Dec 2020	13F
Sonic Fund II, L.P.	13F	Company	23%	5,101,787	$55,303,000	—	31 Dec 2020	13F
Versant Venture Management, LLC	13F	Company	23%	5,003,892	$54,242,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	20%	4,478,951	$48,553,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	19%	4,264,590	$46,228,000	—	31 Dec 2020	13F
Casdin Capital, LLC	13F	Company	16%	3,650,000	$39,566,000	—	31 Dec 2020	13F
UBS Group AG	13F	Company	13%	2,784,862	$30,187,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	12%	2,682,815	$29,081,000	—	31 Dec 2020	13F
Artal Group S.A.	13F	Company	11%	2,500,000	$27,100,000	—	31 Dec 2020	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	11%	2,404,439	$26,064,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	7.7%	1,709,739	$18,537,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	7.5%	1,657,433	$17,967,000	—	31 Dec 2020	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	6.8%	1,500,000	$16,260,000	—	31 Dec 2020	13F
FRAZIER MANAGEMENT LLC	13F	Company	6.5%	1,437,028	$15,577,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	6.3%	1,387,143	$15,036,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	6.2%	1,364,413	$14,790,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	4.7%	1,051,533	$11,398,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	4.2%	931,700	$10,100,000	—	31 Dec 2020	13F
WS MANAGEMENT LLLP	13F	Company	3.9%	858,000	$9,301,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	3.5%	774,442	$8,395,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	3.1%	677,630	$7,346,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	3%	653,884	$7,087,000	—	31 Dec 2020	13F
Rhenman & Partners Asset Management AB	13F	Company	2.8%	625,000	$6,775,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	2.7%	593,298	$6,432,000	—	31 Dec 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	2.6%	579,809	$6,285,130	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	2.6%	568,010	$6,157,000	—	31 Dec 2020	13F
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA)	13F	Company	2.2%	480,000	$5,203,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	1.8%	397,228	$4,306,000	—	31 Dec 2020	13F
MARSHALL WACE, LLP	13F	Company	1.6%	358,166	$3,882,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	1.5%	337,940	$3,664,000	—	31 Dec 2020	13F
S.c.a. Candriam	13F	Individual	1.3%	298,492	$3,236,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	1.3%	296,223	$3,211,000	—	31 Dec 2020	13F
BARCLAYS PLC	13F	Company	1.3%	294,782	$3,194,000	—	31 Dec 2020	13F
Allianz Asset Management GmbH	13F	Company	1.1%	236,439	$2,563,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	1%	223,919	$2,427,000	—	31 Dec 2020	13F
Stenham Asset Management Ltd	13F	Company	1%	222,000	$2,406,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.8%	176,700	$1,915,000	—	31 Dec 2020	13F
Man Group plc	13F	Company	0.62%	136,423	$1,479,000	—	31 Dec 2020	13F
Soleus Capital Management, L.P.	13F	Company	0.61%	135,992	$1,474,000	—	31 Dec 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.61%	134,629	$1,459,000	—	31 Dec 2020	13F
HARBOURVEST PARTNERS LLC	13F	Company	0.61%	134,154	$1,454,000	—	31 Dec 2020	13F
MASSACHUSETTS INSTITUTE OF TECHNOLOGY	13F	Company	0.61%	134,154	$1,454,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.58%	129,100	$1,399,000	—	31 Dec 2020	13F
ALGERT GLOBAL LLC	13F	Company	0.58%	127,660	$1,384,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.55%	121,800	$1,320,000	—	31 Dec 2020	13F
ADAMS STREET PARTNERS LLC	13F	Company	0.54%	120,739	$1,309,000	—	31 Dec 2020	13F

Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q1 2021

As of 31 Mar 2021, Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) was held by 131 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 95,104,058 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, BlackRock Inc., Sonic Fund II, L.P., ORBIMED ADVISORS LLC, STATE STREET CORP, Versant Venture Management, LLC, VANGUARD GROUP INC, and UBS Group AG. This page lists 131 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

152

Q1 2021 holders

131

Holder diff

-21

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.